Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cardio Diagnostics Holdings (CDIOW) Net Margin (2022 - 2025)

Historic Net Margin for Cardio Diagnostics Holdings (CDIOW) over the last 4 years, with Q3 2025 value amounting to 60053.8%.

  • Cardio Diagnostics Holdings' Net Margin fell 385862300.0% to 60053.8% in Q3 2025 from the same period last year, while for Sep 2025 it was 41516.33%, marking a year-over-year decrease of 183907000.0%. This contributed to the annual value of 24028.24% for FY2024, which is 250595700.0% up from last year.
  • As of Q3 2025, Cardio Diagnostics Holdings' Net Margin stood at 60053.8%, which was down 385862300.0% from 22517.71% recorded in Q2 2025.
  • In the past 5 years, Cardio Diagnostics Holdings' Net Margin ranged from a high of 16365.88% in Q2 2024 and a low of 250321.79% during Q4 2022
  • Its 4-year average for Net Margin is 80283.38%, with a median of 26156.85% in 2023.
  • Per our database at Business Quant, Cardio Diagnostics Holdings' Net Margin skyrocketed by 2000000000bps in 2023 and then plummeted by -1478029500bps in 2025.
  • Cardio Diagnostics Holdings' Net Margin (Quarter) stood at 250321.79% in 2022, then surged by 90bps to 26156.85% in 2023, then decreased by -29bps to 33672.61% in 2024, then tumbled by -78bps to 60053.8% in 2025.
  • Its last three reported values are 60053.8% in Q3 2025, 22517.71% for Q2 2025, and 173942.98% during Q1 2025.